Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning
Ajay R Bharti,1 Steven Paul Woods,2 Ronald J Ellis,3 Mariana Cherner,2 Debra Rosario,3 Michael Potter,3 Robert K Heaton,2 Ian P Everall,4 Eliezer Masliah,5 Igor Grant,2 Scott L Letendre1 On behalf of the Translational Methamphetamine AIDS Research Center Group 1Department of Medicine, 2Department o...
Guardado en:
Autores principales: | Bharti AR, Woods SP, Ellis RJ, Cherner M, Rosario D, Potter M, Heaton RK, Everall IP, Masliah E, Grant I, Letendre SL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/18047a7b2b7b4d2b944e18d84030e522 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities
por: Okazaki K, et al.
Publicado: (2016) -
Age of Onset and Its Related Factors in Cocaine or Methamphetamine Use in Adults from the United States: Results from NHANES 2005–2018
por: Alexandre Arthur Guerin, et al.
Publicado: (2021) -
FREQUENCY OF PSYCHOTIC SYMPTOMS IN METHAMPHETAMINE USERS
por: Ihsan Ullah Kasi, et al.
Publicado: (2020) -
A Zebrafish Model of Neurotoxicity by Binge-Like Methamphetamine Exposure
por: Juliette Bedrossiantz, et al.
Publicado: (2021) -
Effects of Buprenorphine on the Memory and Learning Deficit Induced by Methamphetamine Administration in Male Rats
por: Farshid Etaee, et al.
Publicado: (2021)